What happened
Aprogen Biologics updated the terms of convertible bonds to raise US$14.7M, about 78.5% of its market value.
For context, this raise equals about 78.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$14.7M |
| vs. market value | 78.5% |
| Filed | 2026-09-23, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260923000418 → open original filing |
Versions of this filing
- 2026-09-03Original
- 2026-09-11Amendment 1
- 2026-09-23Amendment 2 (this page)
Source: DART. Information only, not investment advice.